European Society of Toxicology In Vitro > News > ATLA Launching 4 special issues on NAMs!
1 April 2021

ATLA Launching 4 special issues on NAMs!

The four special virtual issues are focusing on:

  • Biobanking – discuss the suitability of your MS with the VSC Editor Rita Seabra <rita@frame.org.uk>
  • In silico tools – discuss the suitability of your MS with the VSC Editor Judith Madden <J.C.Madden@ljmu.ac.uk>
  • Serum-free approaches – discuss the suitability of your MS with the VSC Editor Helena Kandarova <helena.kandarova@outlook.sk>
  • Educational resources – discuss thesuitability of your MS with the VSC Editor Esther Haugabrooks <EHaugabrooks@pcrm.org>

Articles will be made available online (subject to access rights) as soon as they are published.
• High visibility on the award-winning SAGE Journals platform, securing a wide international audience, including researchers, policymakers and educators.
• Prompt publishing and no submission or publication fees payable.

About the journal
ATLA is a peer-reviewed international journal that has been at the forefront of promoting and publishing on all aspects of the development, validation, implementation and use of animal alternatives, for almost 50 years. In addition to the replacement of animals, it also covers work that aims to reduce the number of animals used and refine the in vivo experiments that are still carried out (the Three Rs).

Related content

APRIL ESTIV-ASCCT Webinar: Legal and Policy Considerations for in the Use of New Approach Methodologies (NAMs) in Chemical Risk Assessment

APRIL ESTIV-ASCCT Webinar: Legal and Policy Considerations for in the Use of New Approach Methodologies (NAMs) in Chemical Risk Assessment – with Gary Marchant, PhD, JD, Sandra Day O’Connor College of Law, Arizona State U. and Kirk T. Hartley, JD, ToxicoGenomica and LSP Group LLC

Webinar + Guidance on gaining acceptance in next generation PBK modelling approaches for regulatory approaches – May 10, 2021

  • News

If you are from the community of PBK model developers, or the proponent of a model in a regulatory submission, or a regulator who needs to assess the applicability of the models in chemical evaluations, this webinar is for you!

The report of the Commission’s Second Annual Forum on Endocrine Disruptors has been published

  • News

The objective of the Second Annual Forum held on December 17-18, 2020 was to present the actions on endocrine disruptors

Corporate Members

mattek in Vitro Life Science Laboratories

Affiliated Societies

Invitrom Celltox IVTS

Memorandum of Understanding